Expansion Centres Hemodialyse Ouest

The centre is evaluating the use of apixaban to prevent stroke in patients with atrial fibrillation who also have advanced kidney disease, aiming to balance efficacy with bleeding risk.

• Assessing stroke and systemic embolism reduction
• Comparing anticoagulation strategies
• Monitoring intracranial and fatal bleeding events

Expansion Centres Hemodialyse Ouest leverages its cardiovascular expertise to improve outcomes for high‑risk patients.

Research focuses on the safety and effectiveness of oral anticoagulants in individuals with Chronic Kidney Disease stage 5 receiving peritoneal dialysis, with the goal of enhancing care for end‑stage renal patients.

• Evaluating anticoagulant use in dialysis settings
• Studying bleeding complications specific to renal failure
• Exploring impact on overall cardiovascular risk

Situated in Laval, France, the site collaborates closely with nephrology specialists to advance therapeutic options for dialysis patients.